Volpara Health Technologies Ltd. (AU:VHT) has released an update.
Volpara Health Technologies Ltd. reported a noteworthy performance in FY24, with a 22% increase in revenue to NZ$42.7M, exceeding their initial forecasts. The company also celebrated a significant improvement in non-GAAP EBITDA, achieving their first positive half-year and closing the year with just a -NZ$0.5M deficit, a 91% improvement from the previous year. Additionally, Volpara marked a milestone with both operating and net free cash flow turning positive, far surpassing expectations.
For further insights into AU:VHT stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
